| This week's sponsor is Signant Health, formerly CRF Bracket. | | | |
| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Friday, June 7, 2019 In the game of executive musical chairs triggered by Sanofi CEO Olivier Brandicourt’s exit, Novartis lost its pharma chief, Paul Hudson. But it was ready with a replacement: Marie-France Tschudin, who joined the company in January 2017 and now joins the ranks of the most powerful women in Big Pharma. |
|
|
Top Stories Of The Week Monday, June 10, 2019 As spring rolls on each year, proxy filings pile up, disclosing executive pay for the prior year. And as in past years, FiercePharma has tracked the info to present the top CEO pay packages in biopharma, ranging from nearly $60 million in 2018 down to $16 million. Monday, June 10, 2019 Last week, Bristol-Myers Squibb announced it was changing up its R&D structure and personnel as it subsumes new buy Celgene, and one of its key executives has now jumped ship to a small British biotech. Friday, June 7, 2019 The Olivier Brandicourt era at Sanofi is nearing an end, and the Paul Hudson era will begin. On Sept. 1, Brandicourt will retire, and Hudson—who was formerly president of Novartis’ pharma business—will take the reins at the French drugmaker. Monday, June 10, 2019 Merck has struck a $773 million detail to buy Tilos Therapeutics. The takeover will give Merck control of a pipeline of cancer, fibrosis and autoimmune programs targeting the latent TGFβ complex. Monday, June 10, 2019 Sanofi’s Toujeo has been battling it out against Novo Nordisk’s Tresiba in the next-generation basal insulin market, but new data could give it an edge in one key pool of diabetes patients. Sunday, June 9, 2019 Back in November, news of a cardiovascular outcomes win for Trulicity pleased Eli Lilly investors analysts considered “skeptical.” Now those same skeptics may wonder just how well Trulicity’s performance can help fend off new competition from Novo Nordisk. Tuesday, June 11, 2019 A cystic fibrosis drug has been approved for use in the U.K. since 2016 but is still being denied to patients over its cost. Now, the question over who is really responsible for its costly creation has arisen. Wednesday, June 12, 2019 After four years of operating under the radar, Medtronic has made its relationship with endoscope manufacturer Karl Storz publicly official in order “to enable upcoming regulatory filings.” Thursday, June 13, 2019 CRISPR-Cas9 gene editing requires cutting DNA, which can lead to errors. Scientists at Columbia University are proposing an alternative that uses a transposon to precisely insert DNA sequences in any site on the genome. Wednesday, June 12, 2019 FDA inspectors continue to chew up Aurobindo Pharma. Just weeks after a stinging report was delivered to Aurobindo’s sterile drug plant in Telangana, the FDA has blasted a finished drug facility there. Resources Sponsored by: AlphaSense What is agile competitive intelligence, and how can it help take market research to the next level? Sponsored by: Reprints Desk, Inc. Get 5 quick tips for faster research and better results! Sponsored by: Blue Latitude Health In this publication, Blue Latitude Health maps the journey of stakeholders impacted by the rise of precision medicine today. Download the report. Sponsored by: Patheon, by Thermo Fisher Scientific Increase Safety & Flexibility with Flow Chemistry Sponsored by: Veeva IONIS shares best practices for implementing an end-to-end RIM solution in this on-demand webinar. Watch now. Sponsored by: WCG Increasingly complex clinical trials place a tremendous burden on study sites, exacerbating already-troubling recruitment and enrollment issues. Overwhelmed, many sites may not be up to the task or have the appropriate infrastructure, creating costly delays that keep new therapies from patients. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Sponsored by: Patheon, part of Thermo Fisher Scientific Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs. Sponsored by: Patheon, part of Thermo Fisher Scientific Designed with speed & flexibility,Quick to Clinic™ for Oral Solid Dose helps deliver products to Phase I Clinic in as little as 14 weeks. |
